Investigation of the Effects of the Technology-based Cardiac Rehabilitation Program in Coronary Artery Patients

NCT ID: NCT05264701

Last Updated: 2024-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-07

Study Completion Date

2024-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular diseases constitute one of the most critical health problems of today's society due to the loss of workforce, morbidity, mortality, and high hospital expenses.

This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Physical Inactivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physiotherapist Supervised Exercise Training Group

Physiotherapist supervised exercise training in patients with coronary artery disease

Group Type EXPERIMENTAL

Physiotherapist supervised exercise training

Intervention Type OTHER

Exercise training for 12 weeks will be given by video talk accompanied by a physiotherapist.

Exercise Training Tracking from Phone-app Group

Exercise training tracking from phone app in patients with coronary artery disease

Group Type EXPERIMENTAL

Exercise training via phone app

Intervention Type OTHER

Exercise training for 12 weeks will be given over the developed phone application.

Control Group

General physical activity recommendations for home

Group Type EXPERIMENTAL

Physical activity recommendations

Intervention Type OTHER

The program will be consist of 12 weeks of physical activity recommendations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiotherapist supervised exercise training

Exercise training for 12 weeks will be given by video talk accompanied by a physiotherapist.

Intervention Type OTHER

Exercise training via phone app

Exercise training for 12 weeks will be given over the developed phone application.

Intervention Type OTHER

Physical activity recommendations

The program will be consist of 12 weeks of physical activity recommendations.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with coronary artery disease
* Access to the online program
* Volunteering to participate in the research
* Having an iOS or Android operating system compatible phone

Exclusion Criteria

* Having a musculoskeletal problem
* Having uncontrolled hypertension
* Having chronic heart failure (NYHA III-IV)
* A history of acute coronary syndrome or surgical revascularization less than 12 months ago
* More than 50% occlusion on the main coronary artery
* Having arrhythmia
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dilara Saklica

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Naciye Vardar-Yagli, PhD

Role: STUDY_DIRECTOR

Hacettepe University

Hikmet Yorgun, PhD

Role: STUDY_DIRECTOR

Hacettepe University

Ahmet Hakan Ates, PhD

Role: STUDY_CHAIR

Hacettepe University

Deniz Yuce, PhD

Role: STUDY_CHAIR

Hacettepe University

Dilara Saklica, MSc

Role: PRINCIPAL_INVESTIGATOR

Hacettepe University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hacettepe University

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KA-20105

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.